Univercells SA raises €44m in first close of its Series D
Belgian CDMO Univercells SA has raised €44m through the first close of its Series D financing round led by Belgian and international investors. I
ADVERTISEMENT
About Thomas Gabrielczyk
This author has not written his bio yet.
But we are proud to say that Thomas Gabrielczyk contributed 1996 entries already.
Entries by Thomas Gabrielczyk
PULSE: At the heart of Switzerlands health valley
Most people know Switzerland for its watches, mountains, and chocolate. But biopharma professionals know that this country in the heart of Europe offers much more: the ideal setting for innovation and production in the fields of pharma and biotech.
Adrenomed set to start pivotal trial in sepsis
German Adrenomed AG has got a recommendation from the EMA to push its Adrenomedullin-binding antibody Adrecizumab into a pivotal Phase III study.
A spotlight on tomorrow’s CRO
The CRO industry is predicted to grow considerably over the next five years. Trials are becoming more complex, and technology is becoming increasingly interwoven with processes. The CRO of tomorrow must be tech smart, agile, and environmentally conscious to remain relevant. In this changing landscape, how does a CRO cut through the noise in 2022-30?
Mablink raises $31m in Series A financing
Mablink Bioscience has baged €31m in a Series A round led by Sofinnova Partners and Mérieux Equity Partners to speed up its pipeline of ADCs.
Experts showcase next-gen biotech solutions to climate crisis
Industry experts have presented the latest biotech solutions for tackling climate change at the first INDUSTRIA BIOTEC conference, Europe’s new forum for the industrial biotech sector.
Stalicla SA and Evgen Pharma plc ink $160.5m licensing deal for SFX-01
Precision neuroscience company Stalicla SA has licensed SFX-01 from Evgen Pharma plc in neurodevelopmental disorders and schizophrenia.
Knowledge-based contract services
To install a newly created Chief Scientific Officer position and to hire a biotech veteran is a signal sent by Rentschler Biopharma, celebrating 150 years.
Clinical Microbiomics A/S bags €10m financing
Danish microbiome specialist Clinical Microbiomics A/S has completed a €10m growth financing led by – Seventure Partners.
EU starts largest study on factors affecting mental health
The EU Commission has granted £8.4m for Youth-GEMS, the largest ever study to identify genetic and other risks affecting mental health in adolescence.